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Higher dietary flavone, flavonol, and catechin intakes are associated
with less of an increase in BMI over time in women: a longitudinal
analysis from the Netherlands Cohort Study1–3
Laura AE Hughes, Ilja CW Arts, Ton Ambergen, Henny AM Brants, Pieter C Dagnelie, R Alexandra Goldbohm,
Piet A van den Brandt, and Matty P Weijenberg
ABSTRACT
Background: Dietary flavonoids are suggested to have antiobesity
effects. Prospective evidence of an association between flavonoids
and body mass index (BMI) is lacking in general populations.
Objective: We assessed this association between 3 flavonoid sub-
groups and BMI over a 14-y period in 4280 men and women aged
55–69 y at baseline from the Netherlands Cohort Study.
Design: Dietary intake was estimated at baseline (1986) by a vali-
dated food-frequency questionnaire. BMI was ascertained through
self-reported height (in 1986) and weight (in 1986, 1992, and 2000).
Analyses were based on sex-specific quintiles for the total intake of
6 catechins and of 3 flavonols/flavones. Linear mixed effect mod-
eling was used to assess longitudinal associations in 3 adjusted
models: age only, lifestyle (age, energy intake, physical activity,
smoking status, alcohol intake, type 2 diabetes, and coffee consump-
tion), and lifestyle and diet (vegetables, fruit, fiber, grains, sugar,
dessert, and dieting habits).
Results: After adjustment for age and confounders, the BMI (kg/m2)
of women with the lowest intake of total flavonols/flavones and total
catechins increased by 0.95 and 0.77, respectively, after 14 y.
Women with the highest intake of total flavonols/flavones and total
catechins experienced a significantly lower increase in BMI of 0.40
and 0.31, respectively (between group difference: P  0.05). This
difference remained after additional adjustment for dietary determi-
nants and after stratification of median baseline BMI. In men, no
significant differences in BMI change were observed over the quin-
tiles of flavonoid intake after 14 y.
Conclusion: Our results suggest that flavonoid intake may con-
tribute to maintaining body weight in the general female
population. Am J Clin Nutr 2008;88:1341–52.
INTRODUCTION
It is well accepted that overweight and obesity are major con-
tributors to the global burden of chronic disease and disability.
According to the World Health Organization, an individual is
considered overweight if his or her body mass index (BMI; in
kg/m2) is25 and obese if his or her BMI exceeds 30 (1). It is of
great importance to determine effective and safe mechanisms for
maintaining a healthy body weight as the prevalence of over-
weight, and obesity continues to rise at an alarming rate.
The role of dietary intake and modification for weight main-
tenance has traditionally been described in terms of macronutri-
ents and micronutrients; however, emerging evidence suggests
that the flavonoids, a group of nonnutritive phytochemicals with
diverse beneficial biochemical and antioxidant effects (2–9),
may be a dietary factor that can also modulate body weight
(9–24). Present in foods of plant origin such as fruit, vegetables,
tea, wine, seeds, herbs, spices, and whole grains, 6000 natu-
rally occurring flavonoids have been identified and classified
into 6 major subgroups: catechins, flavonols, flavones, fla-
vanones, anthocyanins, and isoflavones (25).
Short-term studies using green tea as a source of catechins
have shown a reduction in body weight and body fat compared
with baseline measurements in overweight individuals (15, 17–
20, 23, 24). The major catechins found in the diet are ()-
catechin, ()-epicatechin, ()-epigallocatechin (EGC), ()-
gallocatechin (GC), ()-epicatechin gallate (ECG), and ()-
epigallocatechin gallate (EGCG) (26). Animal studies have
shown that catechins increase energy expenditure, increase glu-
cose uptake in skeletal muscle, decrease glucose uptake in adi-
pose tissue, and prevent obesity in a dose-response fashion (22,
27). Additionally, animal studies have shown an antiobesity ef-
fect of the major dietary flavonols (quercetin, myricetin, and
kaempferol) and the major dietary flavones (luteolin and apige-
nin) through mechanisms such as influences on glucose uptake
and fatty acid catabolism (16, 21). Recent molecular data suggests
that other subclasses of flavonoids may have an effect on adipokine
secretion and up-regulation of gene expression (9–11, 13).
Applying the findings of human studies to the general popu-
lation is difficult because of the short duration of the interven-
tions and because they included primarily overweight and obese
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subjects (15, 17–20, 23, 24). The Netherlands Cohort Study on
diet and cancer (NLCS) provided a unique opportunity to assess
the association between flavonoid intake and BMI change over
time in the general population. Because the majority of evidence
suggesting an association between flavonoid intake and body
weight currently exists for the catechin, flavonol, and flavone
groups, we focused on only these 3 subclasses in the present
study.
SUBJECTS AND METHODS
Subjects and study design
The NLCS is a prospective cohort study that was initiated in
1986 with the enrollment of 120 852 individuals in the Nether-
lands and with the purpose of investigating the association be-
tween diet and the development of cancer. The cohort included
58 279 men and 62 573 women between the ages of 55 and 69 y
at baseline who completed a self-administered questionnaire on
dietary habits, lifestyle, health, and demographic information.
Municipal registries from throughout the Netherlands were used
to constitute an efficient sampling frame reflective of the general
population. Further details of the design of the NLCS were de-
scribed in previous publications (28–30).
The NLCS is a case-cohort design with a subcohort of 5000
individuals randomly selected from the larger cohort on recruit-
ment into the study. These individuals have been followed-up
biennially from baseline in 1986 for migration and vital status to
estimate person time at risk. Follow-up of the subcohort has also
allowed for the additional accumulation of prospective data re-
garding a number of factors related to body weight and weight
change. This subcohort was the study population used for the
present study.
In our analysis, individuals who returned incomplete baseline
dietary questionnaires, individuals with missing values for
height or weight at baseline, and all prevalent cancer cases other
than skin cancer at baseline were excluded. This resulted in an
initial study population of 4280 individuals. Follow-up measure-
ments specifically regarding BMI were recorded in the years
1992 and 2000, and data were available for 3787 and 2091 indi-
viduals, respectively, at these time points. The study protocol of
the NLCS was approved by the Medical Ethics Committees of
the University Hospital Maastricht and TNO Nutrition in Feb-
ruary 1985 and July 1986, respectively.
Dietary assessment
The measurement instrument used to assess dietary flavonoid
intake at baseline was a self-administered food-frequency ques-
tionnaire (FFQ) consisting of 150 food items (28–30). This di-
etary assessment was part of a larger questionnaire that also
included questions regarding a number of lifestyle factors. The
FFQ was aimed at habitual intake; therefore, dietary intake with
a reference period of 1 y was assessed to account for seasonal
variations in some foods, such as vegetables and fruit (28). For
each item on the questionnaire, the frequency of consumption
was asked on a scale consisting of 7 categories. The number of
servings per consumption frequency was reported in natural units
(eg, slice of bread) or household units (eg, spoonful) or the
individual serving size in grams was asked. For some foods, the
frequency categories were replaced by the number of serving
units taken daily, weekly, or monthly. An open-ended question
was included to account for any foods eaten regularly but not
included in the questionnaire (30). Questionnaire data were key-
entered twice and processed in a manner blinded with respect to
case/subcohort status to minimize observer bias in the coding and
interpretation of data. The questionnaire was shown to be valid
and reliable and is described in greater detail elsewhere (28–30).
The major sources of dietary catechins and flavonol/flavone
intake in our population are similar to other studies in the Dutch
population. These include tea, apples, pears, chocolate, and
broad beans for catechin intake (31, 32) and tea, onions, leek,
apples, pears, and sweet peppers for flavonol/flavone intakes
(33). Information regarding the flavonoid content in different
foods and beverages on the questionnaire was required to enable
the epidemiologic evaluation of these substances (32, 34–36).
This was done individually for catechins, flavones, and flavonols
for every item on the FFQ. To determine catechin concentrations,
tables from Arts et al (31, 32) were used. These tables contain the
catechin content of 24 different fruit and fruit varieties, 27 dif-
ferent types of vegetables and legumes, staple foods, processed
foods, chocolate, 8 types of black tea, 18 types of red and white
wine, apple juice, grape juice, iced tea, beer, chocolate milk, and
coffee commonly consumed in the Netherlands. Furthermore,
these products were sampled multiple times in different seasons
and from different retail outlets (31, 32). Data by Hertog et al (34,
35), derived in a similar fashion, were used to determine the
concentration of flavonols and flavones. Concentrations of each
specific flavonoid are reported for each item on the FFQ in
mg/100 g of fresh weight of edible portion of food and in mg/100
mL of beverage. The flavonoid content of each participant’s diet
was calculated by multiplying the reported consumption fre-
quency and consumed quantity on the FFQ by the assigned fla-
vonoid content of each food.
Ascertainment of BMI
Subjects were followed up biennially since the time of the
baseline questionnaire. At these time points, additional self-
administered questionnaires were mailed to all individuals given
they were still alive and reachable at the same address. If neces-
sary, new addresses were obtained and individuals were con-
tacted there. Height (cm) was self-measured and reported on the
baseline dietary questionnaire. Body weight (kg) was reported on
questionnaires on 3 different occasions: at baseline in the autumn
of 1986 and in the autumn of 1992 and 2000. In 1986 and 1992,
the question was open-ended and phrased as “how much do you
weigh now (kg)?” In 2000, subjects were asked “have you
weighed yourself recently (yes/no)?” If the subjects answered
“yes,” they were directed to an open-ended question, “how much
do you weigh (kg)?” At all 3 time points, the weight measurement
was self-reported. BMI (in kg/m2) was calculated for each time
point by using the recorded weight at each time point divided by
height squared at baseline.
Statistical analysis
Data were analyzed by using Stata (version 9.2; Statacorp,
College Station, TX). All analyses were conducted separately for
catechin and flavonol/flavone intakes and were stratified by sex,
because sex was shown to act as an effect modifier (data not
shown). Flavonol and flavone intakes were considered together
because flavones contributed minimally to total flavonoid intake.
Sex-specific quintiles of total catechins, total flavonols/flavones,
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and specific catechin and flavonol compounds were assessed.
Mean total flavonol/flavone intake and total catechin intake as
well as other population characteristics were analyzed by using
data from the baseline questionnaire. Pearson’s correlation and
one-factor analysis of variance was applied to determine the
correlation between continuous variables and total flavonoid
intake, and a chi-square test was used to assess the association
between total flavonoid intake and categorical variables.
Linear mixed effect (LME) modeling was applied to assess the
change in BMI over time and the longitudinal relation between
flavonoid intake at baseline and BMI at baseline (1986), in 1992,
and in 2000. The mixed model consists of 2 parts: fixed effects
and random effects. Fixed effects describe population slopes for
a set of considered covariates, which include exposures and con-
founders. Random effects describe individual variability in out-
come and in changes over time. By considering individual ran-
dom slopes, this model allowed us to examine the influence of
covariates on the change in BMI over time (37). This model also
accounts for the correlation between repeated measurements on
the same subject and accounts for missing values at various time
points (38).
For the LME model, a categorical time variable was created by
using the values 0, 6, and 14; reflecting the time points (in y) of
the BMI measurements from baseline. Two dummy variables
indicating the 3 time points and 4 flavonoid intake dummy vari-
ables were entered into the model. Furthermore, interactions of
the time dummies with the 4 flavonoid intake dummies (8 inter-
action terms) were included. A random slope for time at the
individual level was obtained by using time as a continuous
variable. Longitudinal information was derived by considering
the regression coefficients of the time dummies and the regres-
sion coefficients of the flavonoid-time interaction terms. The
coefficients of the time dummies reflect the change in BMI over
time (6 and 14 y, respectively) in the lowest quintile. The coef-
ficient of an interaction term gives the difference between the
change in BMI in a quintile after 6 and 14 y and the change in BMI
in the lowest quintile of flavonoid intake as the reference cate-
gory.
In addition to an unadjusted and age adjusted model, we cre-
ated an LME model adjusted for age plus confounding variables.
These variables were identified as being associated with both
BMI and flavonoid intake from the previous literature or were
variables that, when entered in our model, resulted in a 10%
change in the regression coefficients. These included age (y),
total energy intake (kcal/d), coffee drinking (cups/d), physical
activity (min/d), smoking status (current smoker, ex-smoker, and
never smoker), alcohol intake (g/d), and the presence of type 2
diabetes (yes or no). Intervention research has shown a potential
synergistic relation between caffeine and flavonoids (20); there-
fore, we performed an additional stratified analysis testing coffee
drinking as a possible effect modifier.
We hypothesized that individuals with a high intake of dietary
flavonoids would also have a healthier lifestyle and, as a result,
less of an increase in BMI over time. Therefore, we created a
fourth model additionally adjusted for fiber, fruit, vegetable,
grain, desert, and sugar intakes (g/d) and dieting habits in the 5 y
leading up to the baseline questionnaire (yes or no). Furthermore,
we investigated whether an association was present over a range
of BMI values or whether it would be present only in individuals
who had the most weight to lose. Using median BMI at baseline
(women: 24.64; men: 24.80) to classify individuals as having a
low or high BMI, we conducted a stratified analysis adjusting for
initial confounders and the extra dietary and lifestyle factors.
Finally, although LME models should be robust to missing val-
ues, we conducted the initial analysis excluding individuals with
missing BMI measurements at 1 or 2 time points (n  1992
remaining) and excluding individuals who developed cancer be-
tween 1986 and 2000 (n  3496 remaining). All models were
tested for evidence of a linear trend by using the time-by-quintile
interaction. Two-tailed P values 0.05 were considered statis-
tically significant in all analyses.
RESULTS
Baseline population characteristics are presented in Table 1.
Flavonoid intake was higher in women than in men for all inves-
tigated catechins and flavonols/flavones. Compared with
women, men consumed more calories, drank more alcohol, and
had a higher proportion of current and ex-smokers. For both men
and women, higher flavonoid intake was associated with higher
total energy intake, a smaller proportion of current smokers, and
a higher level of physical activity. In men, higher intake was also
associated with older age. The presence of type 2 diabetes did not
differ across quintiles of intake in both sexes (data not shown). In
both men and women, BMI increased slightly from baseline over
time, although this increase was only significant in women (Ta-
ble 2).
The course of BMI change over time in quintiles of total
baseline flavonols/flavones and total catechin intake, adjusted
for confounding variables, is depicted for men and women in
Figure 1 and Figure 2, respectively. Although BMI increased in
each quintile of intake over time, women in the third, fourth, and
fifth quintiles of total flavonol/flavone and total catechin intake
had a significantly lower BMI increase than did women with the
lowest intake. After 14 y, the BMI of women with the lowest
intake of total flavonols/flavones and total catechins had in-
creased by 0.95 and 0.77, respectively. In contrast, women with
the highest intake of total flavonols/flavones and total catechins
experienced a significantly lower BMI increase of 0.40 and 0.31,
respectively (between-group difference for both: P 0.05). The
BMI of men also increased after 14 y in all quintiles of total
intake, but this change was not different between intake groups.
No significant linear trends were observed.
The association between BMI change and specific flavonoid
compounds are presented in Table 3, adjusted for identified
confounders. Results are presented by sex, according to quintiles
of intake, and are interpreted as the change in BMI in each
quintile at a given follow-up time point compared with baseline.
Myricetin intake was associated with a lower BMI increase in
women of the highest quintile after 6 y and after 14 y. Women in
the highest quintiles of ECG, GC, EGC, and EGCG intake had a
significantly lower increase in BMI than did women in the lowest
quintile after 6 y. This association was still observed after 14 y
and was additionally observed in women with the highest intakes
of epicatechin.
To assess the influence of potential confounders, 4 different
models were studied: unadjusted, age adjusted, adjusted for iden-
tified confounders, and adjusted for identified confounders plus
additional dietary and lifestyle factors. Regression coefficients
of the LME analyses for total dietary flavonol/flavone and total
dietary catechin intake are presented in Table 4 and Table 5. We
observed similar associations between BMI change and total
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intake in all models. Even after the data were adjusted for a
number of additional lifestyle factors, women with the highest
dietary flavonoid intake experienced a significantly lower in-
crease in BMI over 14 y than did women with the lowest intake
(0.50 and 0.44 less of an increase, respectively; P  0.05). No
significant linear trends were observed.
Results of the analysis stratified by median BMI at baseline are
presented in Table 6. Total flavonol/flavone and total catechin
intakes were associated with a lower BMI change in women with
a BMI in the low range (24.64) and women with a BMI in the
high range (24.64), although it was not always statistically
significant. Stratification of subjects as coffee drinkers (3
cups/d) or non-coffee drinkers (0 cups/d) suggested that coffee
drinking was not an effect modifier in this population (data not
shown). Our findings did not change when after subjects with
missing BMI measurements at 1 or 2 time points or who devel-
oped cancer after 1986 were excluded (data not shown).
DISCUSSION
Although a number of studies have investigated the effect of
flavonoid intake on body weight and BMI, the few observational
data contributing to this evidence are only cross-sectional in
nature (39–43). We observed, after 14 y, that women in all
quintiles of flavonoid intake experienced an increase in BMI.
However, women with the highest intake of total flavonols/fla-
vones and total catechins had a significantly lower BMI increase
over time than did women with the lowest intake. When body
weight and height were substituted for BMI in the model, women
TABLE 1
Baseline characteristics of the subcohort in the Netherlands Cohort Study
Men
(n 2107)
Women
(n 2173) Correlation with total flavonoid intake1,2 P value3
Demographics
Age (y) 61.3 4.24 61.4 4.3 0.10 0.00
Anthropometrics
Height (m) 176.5 6.7 165.2 6.2 0.03 0.05
Weight (kg) 77.7 9.4 68.5 10.3 0.06 0.00
BMI (kg/m2) 25.0 2.6 25.1 3.7 0.05 0.01
Dietary factors
Total energy intake (kcal) 2169 507 1683 397 0.06 0.00
Total catechins (mg/d)5 57.2 36.9 67.0 39.1 0.99 —
Catechin 4.4 2.8 4.6 2.4 0.65 —
Epicatechin 13.0 7.2 15.0 7.5 0.82 —
Epicatechin gallate 18.6 13.9 22.3 15.0 0.97 —
Gallocatechin 2.8 2.0 3.3 2.2 0.97 —
Epigallocatechin 4.6 3.2 5.4 3.4 0.97 —
Epigallocatechin gallate 13.8 10.4 16.5 11.1 0.97 —
Total flavonol/flavones (mg/d)6 26.4 12.5 29.0 12.7 0.89 —
Quercetin 18.2 9.0 19.6 8.9 0.73 —
Kaempferol 6.8 3.9 7.8 4.1 0.95 —
Myricetin 1.4 0.96 1.6 0.97 0.93 —
Self-reported illness
Type 2 diabetes (%) 3.4 3.6 — 0.02
Lifestyle behaviors
Smoking status (%) — — — 0.00
Never 12.7 58.2 — —
Former 51.5 20.6 — —
Current 35.8 21.2 — —
Alcohol intake (%) — — — 0.01
0 g/d 14.6 32.3 — —
0.1-4 g/d 21.1 35.8 — —
5-14 g/d 26.8 19.0 — —
15-29 g/d 22.6 9.4 — —
30 g/d 14.9 3.6 — —
Physical activity (%) — — — 0.02
30 min/d 18.0 24.4 — —
30-60 min/d 31.1 31.2 — —
60-90 min/d 19.0 22.7 — —
90 min/d 31.9 21.8 — —
1 Sum of total catechin and total flavonol/flavone intake.
2 Reported as pairwise correlation coefficients (continuous variable).
3 P values for continuous variables are from one-factor ANOVA, and P values for categorical variables are from a chi-square test.
4 x  SD (all such values).
5 Sum of catechin, epicatechin, epicatechin gallate, gallocatechin, epigallocatechin, and epigallocatechin gallate.
6 Sum of quercetin, kaempferol, myricetin (flavonols), luteolin, and apigenin (flavones).
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with the highest intake of total flavonols/flavones and total cat-
echins gained 1.00 and 0.95 kg less body weight, respectively.
These observations may have important public health implica-
tions because even moderate elevations in BMI and body weight
over a long period of time have been shown to increase disease
risk (44–51).
Our finding of a protective association between catechin in-
take and BMI in women is supported by human intervention
studies using tea or tea extracts as a treatment for overweight and
obesity. Tsuchida et al (15) reported that, compared with con-
trols, subjects consuming high levels of catechins experienced a
significant decrease in BMI (0.49) after a 12-wk randomized
controlled trial. Treatment consisted of 588 mg catechins/d; sim-
ilar doses were used in other successful intervention studies (18,
20). In our study, the mean total catechin intake in women in the
highest quintile was 125 mg/d. Because this is a much lower
concentration than what was used in intervention studies, it is
interesting that we still observed significant inverse associations
with BMI, even after adjusting for all confounders. Because diet
assessed through the FFQ in our study reflects the diet of indi-
viduals for an entire year preceding baseline, and has been ob-
served to be stable for5 y (29), a much longer exposure time to
these substances is expected compared with the controlled inter-
vention studies described above.
The observation that there was a protective association be-
tween myricetin and BMI in women is intriguing. Myricetin
TABLE 2
Change in BMI from baseline over time for subcohort members of the
Netherlands Cohort Study1
Year
BMI (kg/m2)2
Men
(n 2107)3
Women
(n 2173)
1986 24.95 0.04 25.07 0.04
1992 25.00 0.05 25.25 0.074
2000 25.03 0.06 25.55 0.084
1 All values are x  SE.
2 BMI derived from a linear mixed model including BMI and time.
3 Number of subjects at baseline.
4 Significantly different from baseline, P 0.05.
FIGURE 1. Change in BMI (kg/m2) over 14 y for men in each quintile of
total dietary flavonol/flavone intake (A; P for trend 0.06) and total dietary
catechin intake (B; P for trend  0.95). Graphs derived from linear mixed
models adjusted for total energy intake, physical activity, smoking status,
alcohol consumption, type 2 diabetes, coffee drinking, and age.
FIGURE 2. Change in BMI (kg/m2) over 14 y for women in each quintile
of total dietary flavonol/flavone intake (A; P for trend  0.52) and total
dietary catechin intake (B; P for trend  0.08). Graphs derived from linear
mixed models adjusted for total energy intake, physical activity, smoking
status, alcohol consumption, type 2 diabetes, coffee drinking, and age. *Sig-
nificantly lower BMI increase than in the lowest quintile, P 0.05.
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contributes minimally to the percentage of total flavonols in the
daily diet (52, 53). In our population, tea, onions, and leeks
contributed most to myricetin intake (33). Despite limited evi-
dence in the literature suggesting a direct association between
myricetin and obesity, evidence indicates that myricetin can im-
prove the metabolic profile (54, 55). Although a chance finding
cannot be ruled out, further research regarding the relation be-
tween myricetin and body weight would be of interest.
It is well accepted that major modifiers of BMI change are
energy restriction and physical activity. Although we adjusted
our models for these variables, we also recognized that, because
flavonoids are derived from healthy foods, individuals with the
highest flavonoid intake likely had an overall healthier lifestyle
than did those with the lowest intake, and this phenomenon may
result in less of a BMI increase over time. When we attempted to
control for further potential confounding in our model by ac-
counting for intake of vegetables, fruit, grains, fiber, sugar,
deserts, and dieting habits, our observations did not change.
Although residual confounding cannot be ruled out entirely, our
results suggest that there is an independent association between
dietary flavonoid intake and BMI change in women.
There was a clear association between flavonoid intake and
BMI change in women, but this was not the case in men. De-
scriptive analyses at baseline showed that over each quintile of
intake, mean consumption of both total flavonols/flavones and
catechins was higher in women than in men. This observation is
supported by a previous study examining catechin intake in the
general Dutch population, which estimated the average intake of
the 6 major catechins as 50 mg/d, with a significantly higher
intake in women than in men (60 compared with 40 mg/d, re-
spectively) (36). It is possible that flavonoid consumption in men
may not have been high enough for an association to be observed.
Additionally, our analysis showed that, in general, BMI in-
creased much less over time in men than in women.
Our study had many strengths. Although only baseline data on
flavonoid intake and other dietary information were available,
the FFQ used in the NLCS was shown to be reproducible over a
period of5 y (29). It is well established that flavonoid concen-
trations can vary according to growing season, transportation,
and food processing, and these limitations can result in inaccu-
rate reporting of flavonoid concentrations in composition data-
bases. We attempted to control for this by using sources of high
quality to calculate the flavonoid concentrations of food on the
FFQ (31, 32, 34, 35). However, it should be noted that the con-
centrations we calculated may still have been influenced by these
limitations. Human intervention studies have generally admin-
istered tea, or specific catechins isolated from tea, as a treatment
for weight loss. It has been proposed that the results from several
of these studies were attributable to caffeine or to a synergistic
effect between caffeine and catechins rather than to catechins
alone (20). We considered coffee drinking a proxy for caffeine in
our adjustment and also observed no effect modification in an
additional analysis stratified for low and high coffee drinkers.
However, it should be acknowledged that we could not account
for all sources of dietary caffeine, such as from tea and cocoa. We
considered flavonoid intake from the whole diet, which accounts
for a wide variety of food sources and allowed for a more com-
plete estimate of total flavonoid intake. Finally, we accounted for
a number of lifestyle and dietary factors suggested to be impor-
tant when studying the health effects of flavonoids using epide-
miologic data (25, 36).
Our results are questionable because of the use of self-reported
weight and height to ascertain BMI in our population. Although
the measurement of self-reported weight was not independently
validated in the NLCS, many examples in the literature suggest
that this method is a valid and reliable tool for assessing body
weight and height in cohort studies. Analysis of large cohorts
conducted in the Japanese, British, Swedish, and American
working population have all concluded that self-reported weight
and height are generally valid and reliable (56–59); however,
there is a general tendency for women, especially overweight
women, to underreport weight and for men to overreport height.
An underestimation of weight and an overestimation of height
will underestimate BMI and, as a result, will underestimate the
prevalence of overweight and obesity (56–58). Although mis-
classification could not be ruled out, the associations we ob-
served between dietary flavonoid intake and BMI may actually
have been stronger than we reported if the overweight women in
our study had underestimated their weight
The age group of our population was also a limitation. The
subjects were55 y of age at baseline and thus became elderly
over the course of the 14 y of the study. For many subcohort
members, only 1 or 2 weight measurements were available for
analysis. To check for survivorship bias, we conducted an addi-
tional analysis using only those subjects who reported all 3 BMI
measurements, and our results did not change. Because of the
design of the NLCS, we were also able to reconduct the analysis
after eliminating individuals who developed cancer at some time
point between 1986 and 2000. We observed that the BMI change
in women in the highest quintile remained significantly lower
over the 14 y period than did BMI change in the women with the
lowest intake.
The FFQ used in the NLCS only measured flavonoid intake as
derived from food in the daily diet. In response to the growing
public interest in dietary supplements, especially with respect to
weight loss and weight maintenance, epidemiologic studies
should consider the effect of individual flavonoid extracts and
supplements on BMI in addition to dietary food sources, and
intervention studies should study the safety of consuming high
concentrations of supplements on a regular basis (60, 61). Fi-
nally, although the bioavailability of flavonoid subclasses such
as the anthocyanidins are quite low (62, 63), future studies may
consider investigating the association between these flavonoids
and BMI change, because emerging evidence suggests that they
may also possess mechanisms to modulate body weight.
In conclusion, our finding of a significant inverse association
between dietary flavonoid intake and BMI increase in women
suggests that, over time, flavonoid intake may be useful for
weight maintenance, even in persons who are not obese. On a
population level, it is relatively easy to increase one’s flavonoid
intake through the daily diet.
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